Diagnomics on Cloud

Diagnomics-on-Cloud is based on a sequencing partnership between Diagnomics and EONE-Diagnomics (EDGC), a certified clinical sequencing laboratory located in Songdo, South-Korea. In the US, Diagnomics has filed for the first US CLIA88-certified NIPT bioinformatics solutions using a secure cloud environment. The test allows for fast turn-around time, low-cost analysis and low-input sample requirement.

The NICE® test is a safe, accurate, and easy to perform non-invasive prenatal test. This test can be utilized as early as 10 weeks of gestation time. The results are provided in approximately 10 days from receipt of the sample.

Breast cancer, which ranks at the top of all female cancers, affects 1 in 8 women within their lifetime. Cancer occurs due to environmental and genetic factors, and hereditary cancers account for 5-10% of all cancers

– no content –